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Marrow stromal cells (MSC) and neonatal calvarial cells have the potential to differentiate and express markers of mature
osteoblasts. Furthermore, MSCs can generate multiple differentiated connective tissue phenotypes. These properties and
their ability to be expanded ex vivo make them good models for ex vivo gene therapy. In this study we examined the ability
of vesicular stomatitis virus (VSV-G) pseudotyped retroviral vectors to transduce osteoprogenitor cells derived from bone
marrow and from neonatal calvaria. Retrovectors encoding either b-galactosidase or green fluorescent protein (eGFP) were
used for transduction of primary murine marrow stromal and primary neonatal calvarial cell cultures. High infection efficiency
was demonstrated by fluorescence-activated cell analysis when GFP was used as a marker or by estimating the number of
b-galactosidase-positive cells. Expression of markers of differentiated bone cells, including Col1a1, bone sialoprotein, and
osteocalcin mRNA and alkaline phosphatase activity was not impaired by retroviral transduction. Our data suggest that
VSV-G pseudotypes retroviral vectors are suitable for introducing genes into osteoprogenitor cells without affecting
osteoprogenitor lineage progression. © 2001 Academic Press
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Primary murine marrow stromal cell (MSC) and pri-
mary neonatal calvarial osteoblast cultures (mCOB) are
two models currently used to study differentiation of
osteoprogenitor cells (Aubin, 1998; Friedenstein, 1995;
Malaval et al., 1994; Owen and Friedenstein, 1988). De-
pending on the culture conditions, MSC have the poten-
tial to differentiate into cells of several lineages such as
osteoblasts, chondrocytes, adipocytes, and myocytes.
Compared to MSC that originate from mesoderm, calvar-
ial osteoprogenitors arise from neuroectoderm (Dennis
et al., 1999; Malaval et al., 1999; Nefussi et al., 1997).
Calvarial cell culture consists of mixed cell populations;
some express markers of differentiated osteoblasts,
whereas some represent a population of undifferentiated
progenitor cells (Aubin et al., 1982). In both by 7 days of
culture, alkaline phosphatase (ALP)-positive colonies be-
gin to form, while the markers of osteoblast differentia-
tion at the mRNA level develop in the second and third
week of culture.
MSC meet the important requirements for somatic
gene therapy. They contain osteoprogenitor cells that
undergo a number of divisions prior to attaining a differ-
entiated osteoblastic phenotype. Marrow stromal-de-
rived progenitors can be easily obtained from a patient,
1 To whom correspondence and reprint requests should be ad-
ressed at the Department of Genetics and Developmental Biology, MC
231, University of Connecticut Health Center, 263 Farmington Avenue,
armington, CT 06030. Fax: (860) 679-8345. E-mail: lichtler@
anda.uchc.edu.
37expanded in vitro, and engineered by a number of meth-
ods. Once transplanted into the blood stream, MSC were
reported to have the ability to home to the bone (Keating
et al., 1982; Nilsson et al., 1999). Using marrow stromal
osteoprogenitor cells as a vehicle for somatic gene ther-
apy, a number of diseases can be targeted, including
genetic disorders like osteogenesis imperfecta. Indeed,
mouse models of osteogenesis imperfecta (OI) pheno-
type can be used as convenient models to test the
effects of somatic gene therapy protocols (Chipman et
al., 1993; Forlino et al., 1999; Pereira et al., 1993).
In order to engineer osteoprogenitor cells to inhibit
defective gene expression or to overexpress different
growth factors, various types of gene delivery are used.
Viral vector delivery has become a frequently used sys-
tem to deliver a gene into mammalian cells. A broad
spectrum of retroviruses, adenoviruses, adeno-associ-
ated viruses, herpes simplex virus, and lentiviral vectors
are being used as tools to achieve long-term expression
of the DNA of interest in targeted cells (Mulligan, 1993).
Replication-defective retroviral vectors are produced by
introduction of a viral genome into a packaging cell line.
The packaging cell lines have been stably transfected by
plasmids encoding the viral structural genes gag, pol,
and env in order to provide all components necessary to
produce retroviral vectors. Vesicular stomatitis virus
(VSV) pseudotyped retrovectors can yield high titers of
stable viral particles capable of gaining entry to various
cell types because the G glycoprotein of VSV interacts
with the phospholipid of the cell membrane (Burns et al.,
1993; Emi et al., 1991; Yee et al., 1994a,b). Moreover, use
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38 KALAJZIC ET AL.of polycations like polybrene and protamine sulphate
has been shown to increase transduction efficiency with-
out major toxic effects (Cornetta and Anderson, 1989;
Manning et al., 1971). The major disadvantage of these
vectors is the inability to transduce nondividing cells
(Roe et al., 1993).
We used the 293GPG packaging cell line, in which the
G protein is under the control of the tetracycline-respon-
sive element (tet off system) (Ory et al., 1996). The aim of
his study was to examine the ability of VSV-G
seudotyped retrovectors to introduce exogenous genes
nto murine osteoprogenitor cells without using addi-
ional antibiotic selection. We also wanted to determine
hether transduction of these cells altered their ability to
ndergo osteogenic differentiation in vitro.
RESULTS
ransduction of primary osteoblast cultures
VSV-G pseudotyped retroviral vectors encoding b-ga-
actosidase (b-gal) (MFG.S.nlsLacZ) (Fig. 1A) or green
fluorescent protein (eGFP) (MG1) (Fig. 1B) were used to
transduce osteoprogenitor cells. Both vectors contain
long terminal repeat promoter and enhancer elements.
The eGFP-encoding vector also has a cytomegalovirus
(CMV) promoter driving the eGFP marker and the neo-
mycin resistance gene.
Infection efficiency in MSC cultures. Marrow stromal
cell colonies arise as a single clonal population of os-
teoprogenitor cells. In order to target early progenitor
cells, infections were done on days 4, 5, and 6 as soon
as the cells were viable without the supporting hemato-
poietic layer. Depending on the titer of the retroviral
vector, different levels of transduction efficiency were
observed. The vector encoding the GFP transgene had a
lower titer (5 3 104–1 3 105) compared to that of the
lacZ-encoding vector (1–5 3 106) and this difference was
FIG. 1. Retroviral vectors. (A) The retrovector encoding a nuclear loc
construct contains 59 and 39 long terminal repeats that include prom
retrovector encoding green fluorescent protein (eGFP) has a GFP mar
for neomycin resistance that is driven by an SV40 promoter.eflected in the level of infection, as shown in Figs. 2A,
B, and 3. Using FACS analysis, we were able to detect
c
transduction of 15 to 20% of MSC (Fig. 2C). The detection
f transduced cells using b-galactosidase staining
howed a high percentage of b-galactosidase-express-
ing stromal cells at day 10 of culture, as seen on digital
images of tissue culture plates (Fig. 3A), as well as
individual colonies (Figs. 3B, 3C).
Infection efficiency in mCOB cultures. Mouse neonatal
calvarial cells were derived from sequential enzymatic
digestion of whole neonatal calvariae. They began to
grow as single cell colonies and become a monolayer by
day 7 of culture. If cultured in differentiation medium
(ascorbic acid, b-glycerol phosphate), they produce mul-
ilayered colonies (nodules) and express bone differen-
iation markers such as bone sialoprotein and osteocal-
in. Using fluorescent microscopy, we detected a large
umber of GFP-expressing cells (Figs. 4A and 4B). This
bservation was confirmed by fluorescence-activated
ell analysis. Analysis showed that up to 50% of the cells
ere transduced by the eGFP encoding retrovector (Fig.
C). Staining for b-galactosidase also revealed high
transduction efficiency in primary neonatal calvarial
cells. Ten-day-old culture showed uniform expression
over the entire culture well (Fig. 5A) and phase contrast
microscopy images showed that most cells express the
transgene (Figs. 5B and 5C).
Effect of infection on differentiation of
osteoprogenitor cells
The ability of transduced cells to undergo osteoblast
lineage progression was evaluated. In the presence of
osteoblast differentiation media that included dexameth-
asone, ascorbic acid, and b-glycerol phosphate, both
stromal cell cultures and calvarial cultures showed alka-
line phosphatase-positive colonies, type I collagen, bone
sialoprotein, and osteocalcin mRNA expression. As the
retrovector encoding b-galactosidase showed a higher
ate of infection both in the MSC and in calvarial cell
n signal (nls) for the b-galactosidase gene (MFG.S.nlsLacZ). The viral
d enhancer sequences and a termination codon sequence. (B) The
en by a CMV early promoter (MG1). The vector includes a sequencealizatio
oter anultures, cells transduced with this vector were used to
est their differentiation potential.
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39RETROVIRAL TARGETING OF OSTEOPROGENITOR CELLSDifferentiation of MSC cultures. There were no differ-
ences in the spatial distribution and in the temporal
pattern of alkaline phosphatase expression in control
and infected MSC cultures. b-Galactosidase-positive
colonies were detected in infected cultures but not in the
control cultures, and infected colonies had levels of
alkaline phosphatase expression similar to those of un-
FIG. 2. Transduction of MSC cultures with a GFP-encoding retrovec-
or. (A) Primary marrow stromal cell cultures were established from
-month-old CD-1 mice. After repetitive infection on days 4, 5, and 6,
SC were imaged using fluorescent microscopy (A, 103 magnifica-
tion) and a composite image of transmitted and fluorescent light was
obtained using Photoshop 5.0 (B). Fluorescent-activated cell analysis of
MSC culture (C).infected wells (Fig. 6A). Likewise, the expression of os-
teoblast differentiation markers like type I collagen
a
n(Col1a1), bone sialoprotein (BSP), and osteocalcin (OC)
was similar in infected and in control cultures (Fig. 6B).
Differentiation of mCOB cultures. Similar results were
observed in mCOB cultures that normally show homoge-
neous expression of ALP throughout the culture (Fig. 7A).
There was no difference in mineralization between the
uninfected and infected cells, as shown on Fig. 6A,
whereas numerous b-galactosidase-positive cells were
observed under and inside the mineralized regions of the
calvarial cell cultures (Figs. 7B and 7C). Strong GFP
expression was seen in cells that constitute the miner-
alized region of a nodule, as well in cells in internodular
positions (Figs. 7D and 7E). Col1a1, BSP, and OC mRNA
levels were similar in transduced and control cells. Thus,
viral infection did not affect the ability of cells to undergo
osteoblastic differentiation (Fig. 7F).
DISCUSSION
Our data suggest that primary murine osteoprogenitor
cells can be efficiently transduced with VSV-G
pseudotyped retroviral vectors without affecting their
ability to differentiate down the osteoblast lineage.
The basis of gene therapy protocols that use retroviral
vectors as tools to deliver a gene of interest is to target
a specific cell type. Introduction of exogenous genes has
been evaluated in a number of studies using replication-
defective retroviral vectors in secondary cultures of
mouse, rat, or human osteoprogenitor cells (Abboud et
al., 1998; Onyia et al., 1998; Oyama et al., 1999). These
tudies showed a high rate of infection, but used cells
hat had undergone a significant number of passages.
his may increase the potential of these cells to undergo
pontaneous transformation, decreased life span, or re-
uced differentiation ability. In contrast, our study was
ocused on achieving efficient transduction into primary
ell cultures that we believe most closely resemble in
ivo osteoblast progenitors.
Mouse marrow stromal cells develop into colonies
hen cultured in the presence of a hematopoietic “sup-
ortive” cell layer and have the ability to progress to
steoblast lineage if cultured under osteoblast-inductive
onditions (Friedenstein et al., 1992; Kuznetsov et al.,
997). As our interest was to target early precursor cells,
he presence of hematopoietic feeder cells that outnum-
er the stromal adherent population and therefore com-
ete for the viral particles in the supernatant presented a
roblem. Hematopoietic cells were removed and MSC
ere exposed to viral supernatants. Because after day 4
tromal cells could develop without a supportive micro-
nvironment of hematopoietic cells, we performed the
nfection starting at this time point. However, by day 4 in
ulture osteoprogenitor cells had already started to pro-
iferate, resulting in at best an infection rate of 40–50%,
long with a distribution that showed the presence of
ontransduced or partially infected colonies. In contrast
1
dFIG. 3. Transduction of MSC cultures with nlsLZ2 retrovector. (A) Digital images of 35-mm tissue culture wells showing a distinct pattern of
transduced colonies. (B) Light microscopy images of transduced MSC under 103 and 203 magnification (C) show strong blue staining of nuclei in
numerous cells.
FIG. 5. Transduction of mCOB cultures with nlsLZ2 retrovector. After repeated infection, cells were stained for b-galactosidase expression. (A)
Targeted clonal populations can be observed macroscopically as a layer of blue nuclei. Targeted cells after a number of divisions formed a layer of
cells that stained positive for marker gene expression as shown under 103 (B) and 203 (C) magnification under phase optics.
FIG. 6. Osteoblastic differentiation of transduced MSC. Marrow stromal cells were grown in the presence of differentiation medium (dexameth-
asone 10-8 M, 50 mg/ml ascorbic acid, and 8 mM b-glycerol phosphate. (A) Cultures were stained for alkaline phosphatase (ALP) expression on days
1, 15, and 18. Sister cultures of both infected and noninfected cells were stained for b-galactosidase expression. (B) Northern analysis of total RNA
erived from infected MSC were probed for lacZ, Col1a1, BSP, and OC transcripts on days 15 and 18 of MSC culture.40
FIG. 7. Osteoblastic differentiation of transduced mCOB. Cells were stained for the expression of alkaline phosphatase (ALP) on days 10 (data not
shown), 15, and 20 (A). Mineralization was assessed using silver staining by the Von Kossa (VK) method (A). Light microscopy of mineralized regions
in noninfected (B) and infected (C) calvarial cells under 103 magnification. Transduced cells expressing the GFP signal were observed under
transmitted light (D) and under a fluorescent light (E). (F) Northern blot analysis of mCOB transduced with both retrovectors and uninfected culture
(mock). Cultures were grown under differentiation conditions and total RNA was extracted on days 10, 15, and 20. The lane labeled as control (ctrl)
represents RNA derived from cells that were not exposed to conditioned media or to protamine sulphate. Filters were hybridized with cDNAs for GFP,
LacZ, Col1a1, BSP, and OC. Ethidium bromide staining was used to assess RNA loading.41
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42 KALAJZIC ET AL.to stromal cell cultures, calvarial osteoblasts do not re-
quire the presence of supportive cells. Therefore, the
infection could be performed at earlier time points (after
the cells had attached to a plate), resulting in a much
higher rate of infection. Increasing the infection rate in
primary MSC needs to be addressed by additional ex-
periments. Conditioned media that had been described
as supporting stromal cell growth (Lennon et al., 1995)
FIG. 4. Transduction of mCOB cultures with the GFP-encoding ret-
rovector. Mouse calvarial osteoblast cultures were infected on days 2,
3, and 4 of primary culture. (A) Fluorescent image of transduced mCOB,
103. (B) This image represents a composite of transmitted and fluo-
rescent light in 10-day-old primary mCOB cultures. (C) Fluorescence-
activated cell analysis of 10-day-old mCOB shows expression of the
trangene in 50% of the cells.could be used in combination with a higher titer of virus.
Furthermore the VSV-G pseudotyped retroviral particlesare stable enough to support two rounds of ultracentrif-
ugation that can increase the titer up to 1000-fold (Burns
et al., 1993).
Recent studies have shown that retroviral infection
was successful in secondary culture of human marrow-
derived mesenchymal progenitor cells in expressing fac-
tors such as human interleukin-3 (Allay et al., 1997)
ithout affecting the osteogenic ability of transduced
ells. Transplantation of human bone marrow cells has
een applied in human subjects with osteogenesis im-
erfecta (Horwitz et al., 1999), resulting in engraftment of
–2% of stromal cells with questionable success in pri-
ary disease improvement (Bianco and Gehron Robey,
000). These protocols require a severe preoperative
reatment, and they raise ethical questions. We believe
hat it is premature and inappropriate to carry out studies
esting engraftment of stromal cells on human subjects.
his suggests the importance of testing gene therapy
rocedures based on the use of retroviral vectors in
urine models.
Our experiments were designed to achieve efficient
ransduction of osteoprogenitor cells and to test the
steogenic differentiation ability of both murine marrow-
erived mesenchymal progenitor cells and calvarial pro-
enitors after transduction with VSV pseudotyped ret-
ovectors. We observed that there were no changes in
ineralization and osteocalcin expression as well as the
xpression of other bone-related genes like BSP, ALP,
nd type I collagen following the transduction. Further-
ore, the mineralized areas contained cells expressing
trong transgene signals suggesting that cells infected
uring the progenitor stage continued to express trans-
ene while attaining their fully differentiated osteoblastic
henotype.
In summary, we have demonstrated the capability of
SV-G pseudotyped retroviruses to transduce murine
steoprogenitor cells without affecting their proliferation
nd differentiation capabilities. Our data indicate the
dvantages and reliability of using VSV-G pseudotyped
etroviral vectors in future gene therapy studies.
MATERIAL AND METHODS
roduction of pseudotyped retroviral vectors
In this study we used retroviral vectors that encode
ither the marker gene b-galactosidase (MFG.S.nlsLZ) or
an enchanced version of green fluorescent protein
(MG1) (Fig. 1). Both retroviruses were produced by
the human embryonic kidney cell line 293GPG. The
GPGnlsLacZ2, a high-titer producer cell line of the
MFG.S.nlsLZ vector, was a generous gift from Dr. R. C.
Mulligen (Ory et al., 1996). MG1, an eGFP-encoding retro-
vector made by introducing a CMV promoter driving
eGFP into the pLXSN vector (Miller et al., 1993), was
kindly provided by Dr. D. Dorsky. The MG1 retrovector
was transfected into 293GPG cells, followed by expan-
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43RETROVIRAL TARGETING OF OSTEOPROGENITOR CELLSsion of the brightest clone to obtain a high-titer producer
cell line. The 293GPG packaging cell lines were grown in
Dulbecco’s modified Eagle medium with 5 g glucose/L
(DMEM—high glucose, GIBCO BRL), with 10% heat-in-
activated fetal bovine serum (FBS), 2 mM L-glutamine,
and 50 U/ml penicillin and streptomycin. Antibiotic se-
lection was maintained in media with 2 mg/ml puromycin,
1 mg/ml tetracycline, and 0.3 mg/ml G418. A producer cell
ine for the nlsLZ2 retrovector was additionally supple-
ented with 100 mg/ml of zeocyn. In order to produce
etroviral particles, antibiotics were removed and me-
ium was collected and pooled after 24, 48, 72, and 96 h.
he samples contained complete viral particles with
SV-G glycoprotein in the envelope.
Viral titers were determined using the DF1 fibroblast
ell line. Cells were grown in DMEM—high glucose, 5%
BS and 5% fetal calf serum (FCS) supplemented with 7
/L tryptose phosphate, 100 U/ml penicillin, and 100
mg/ml streptomycin. Cultures were passaged into 24-
well plates until reaching 30–40% confluence, after which
they were incubated overnight with varying dilutions of
the viral supernatants containing 8 mg/ml of polybrene.
wo days after infection, cells were stained for b-galac-
osidase activity when nlsLZ2 vector was used, or fluo-
escent colonies were counted for the eGFP-encoding
ector. The viral titer was calculated from the number of
b-galactosidase or GFP-expressing colonies with a cor-
rection for the dilution factor.
Isolation and cultivation of cells
Preparation of mouse primary marrow stromal cell
culture. Femurs and tibiae from 2-month-old CD-1 mice
ere dissected and cleaned of attached muscle. The
piphyseal growth plate was removed, and the marrow
as collected by flushing culture medium (aMEM con-
taining 100 U/ml penicillin, 100 mg/ml streptomycin, and
0% FCS) through the bone with a 25-gauge needle. A
ingle-cell suspension was achieved by 4–5 cycles of
spiration and expulsion through an 18-gauge needle
ollowed by filtration through a 70-mm cell strainer (Fal-
on, Cat. No. 2350). Approximately 20 3 106 cells per
well (four wells per mouse) were seeded in six-well
tissue culture plates (Falcon, Cat. No. 3046). On day 4,
media containing nonadherent cells were removed and
the infection procedure was initiated (see below). Start-
ing from day 7, media were supplemented with 25 mg/ml
scorbic acid, dexamethasone (1028 M), and b-glycero-
phosphate (8 mM) and were changed every two days.
Preparation of mouse primary neonatal calvaria cell
cultures. Isolation of calvarial cells was performed by a
modification of the method of Wong and Cohn (1975).
Briefly, calvariae from 7- to 9-day-old CD-1 mice were
dissected and the sutures were removed. Calvariae were
subjected to four sequential 15-min digestions in an
enzyme mixture containing 0.05% trypsin (Life Technolo-gies, Inc.) and 0.1% collagenase P (Boehringer Mann-
heim) at 37°C on a rocking platform. Fractions 2–4 were
collected and cooled by the addition of an equal volume
of cold DMEM containing 10% FCS, 100 U/ml penicillin,
and 100 mg/ml streptomycin. The fractions were pooled,
centrifuged, resuspended in DMEM containing 10% FCS,
and filtered through a 70-mm cell strainer (Falcon, Cat.
No. 2350). Cells were plated at a density of 1–1.5 3 104
cells/cm2 in 35-mm six-well plates in DMEM containing
10% FCS. Cells were given fresh DMEM containing 10%
FCS (basal medium) 24 h later and fed again with this
medium 3 days later. Viral infections were initiated at this
time point (see below). At 1 week of culture, the medium
was changed to differentiation medium (aMEM contain-
ing 10% FCS, 25 mg/ml ascorbic acid, 4 mM b-glycero-
hosphate) and thereafter the medium was changed
very 2 days.
nfection of primary cultures
Both calvarial and marrow stromal cells were infected
hree times during the period of high proliferation in the
resence of 8 mg/ml protamine sulphate. On days 4, 5,
nd 6, MSC were washed in PBS once and exposed to 2
l of virus for 6 h, whereas calvarial cells were infected
n days 2, 3, and 4 of culture using the same protocol.
ninfected cells that were exposed to 8 mg/ml protamine
sulphate in media collected from 293GPG producer cells
that did not contain any retrovector were used as a
control (mock). Although it is possible to select the cells
by the addition of G418 to the medium, we did not employ
this option in the present study.
Flow cytometry analysis was carried out on a FACS-
can/Calibur (Becton–Dickinson) using a 488-nm excita-
tion wavelength generated by a 15-MW argon ion laser.
Emission was detected using a 500-LP (GFP) filter in FL1.
Nontransduced calvarial or marrow stromal cells were
used as a control.
Fluorescent images of mineralized nodules were ob-
tained using an Olympus IX50 inverted system micro-
scope equipped with an IX-FLA inverted reflected light
fluorescence. A specific excitation wavelength was ob-
tained using an additional filter with excitation at 488 nm.
In addition, images were taken under regular light mi-
croscopy as a grayscale image.
Staining for b-galactosidase was performed on cul-
tures that were washed once in 0.1 M phosphate buffer,
pH 7.3, fixed for 5 min in 0.8% glutaraldehyde, 5 mM
EGTA, and 2 mM Mgcl2, and washed three times with
washing buffer (0.02% Nonidet P-40, 0.1% deoxycholate in
0.1 M sodium phosphate). Cells were stained overnight
at 37°C in a 1 mg/ml concentration of X-gal (Bethesda
Research Laboratories) and potassium ferrocyanide
(Sigma P-9387, P8131). The infection rate was based on
an estimate of the number of cells with blue nuclei
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44 KALAJZIC ET AL.compared to the number of negative cells in several
visual fields.
Histochemical analysis
Alkaline phosphatase staining was performed accord-
ing to the manufacturer’s instructions (Sigma kit No.
86-R). During the incubation period, cells were protected
from direct light exposure and drying. Subsequently,
plates were washed twice in deionized water and air
dried.
Mineralization was assessed by the von Kossa
method. Briefly, cells were fixed for 10 min in 2% para-
formaldehyde in 0.1 M cacodylic buffer, pretreated for 20
min with a saturated lithium carbonate solution, and
washed with deionized water. The plates were incubated
with 5% silver nitrate solution for 30 min under a bright
light, washed with water, and treated with a 5% sodium
thiosulfate solution for 2–3 min, followed by washing with
water and air drying. The results of the staining proce-
dures were recorded with a Kodak DCS420 color digital
camera.
RNA extraction and Northern blot analysis
Total RNA was isolated using TRIzol reagent (GIBCO
BRL) according to the manufacturer’s instructions. The
RNA precipitate was washed once with 80% ethanol and
redisolved in 50 ml of DEPC water. RNA was separated
n a 2.2 M formaldehyde 1% agarose gel and transferred
nto a nylon membrane (Maximum Strength Nytran,
chleicher & Schuell). Membranes were probed with
GFP, b-gal cDNA, rat Col1A1 (pa1R2) (Genovese et al.,
1984), mouse OC (Celeste et al., 1986), and mouse bone
sialoprotein (Young et al., 1994) cDNAs. Probes were
radiolabeled using the random primer method using
[a-32P]dCTP (New England Nuclear, 3000 Ci/mM). Filters
ere hybridized with 3 3 106 cpm/ml at 42°C in 50%
ormamide, 53 SSPE (13 SSPE is 0.149 M NaCl, 10 mM
aH2PO4, 1 mM EDTA, pH 7.4), 1.23 Denhardt’s, 0.5%
odium dodecyl sulfate (Sambrook et al., 1989). Filters
ere washed with 63 SSPE and 0.5% SDS for 10 min at
oom temperature, 0.13 SSPE and 0.1% SDS for 10 min at
7°C, and once in 0.13 SSPE and 0.1% SDS for 10 min at
5°C. Prior hybridization signals were removed by wash-
ng in 0.13 SSPE and 0.1% SDS for 20–30 min at 80°C.
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